Scott Henry
Stock Analyst at Alliance Global Partners
(1.67)
# 2,973
Out of 4,814 analysts
61
Total ratings
37.74%
Success rate
-5.4%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.11 | +171.49% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.14 | +228.95% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.00 | +200.00% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.00 | +233.32% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.61 | +353.20% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $6.21 | +36.88% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.00 | +300.00% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.51 | +893.38% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.71 | +1,581.61% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $8.20 | -8.54% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $11.60 | +12.12% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $23.83 | +0.71% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $105.28 | -14.51% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $22.52 | -31.17% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $86.28 | -32.78% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $51.50 | -30.10% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.02 | +978.43% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.61 | +30.15% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.72 | +211,592.81% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.06 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $4.35 | +60.92% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $15.71 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.73 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.11
Upside: +171.49%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.14
Upside: +228.95%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.00
Upside: +200.00%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.00
Upside: +233.32%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.61
Upside: +353.20%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $6.21
Upside: +36.88%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.00
Upside: +300.00%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.51
Upside: +893.38%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.71
Upside: +1,581.61%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $8.20
Upside: -8.54%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $11.60
Upside: +12.12%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $23.83
Upside: +0.71%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $105.28
Upside: -14.51%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $22.52
Upside: -31.17%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $86.28
Upside: -32.78%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $51.50
Upside: -30.10%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.02
Upside: +978.43%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.61
Upside: +30.15%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.72
Upside: +211,592.81%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $4.35
Upside: +60.92%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $15.71
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.73
Upside: -